Endocrine factors in the treatment of prostatic cancer.

作者信息

Pierrepoint C G, Turkes A O, Walker K J, Harper M E, Wilson D W, Peeling W B, Griffiths K

出版信息

Prog Clin Biol Res. 1985;185A:51-72.

PMID:3162177

Abstract

摘要

相似文献

Endocrine factors in the treatment of prostatic cancer.

Prog Clin Biol Res. 1985;185A:51-72.

Results obtained in the treatment of prostate cancer patients with Zoladex.

Prog Clin Biol Res. 1985;185A:287-95.

[LHRH analogs--new possibilities in the treatment of prostatic cancer].

Pol Tyg Lek. 1984;39(29-30):1009-12.

Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.

Chemioterapia. 1985 Jun;4(3):249-51.

The adrenal cortex and prostatic cancer.

Proc R Soc Med. 1974 Nov;67(11):1156-8. doi: 10.1177/003591577406701125.

[Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].

Hinyokika Kiyo. 1988 Oct;34(10):1853-63.

[Zoladex in prostatic carcinoma].

Drugs Exp Clin Res. 1990;16 Suppl:19-29.

Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.

Br J Urol. 1988 Oct;62(4):352-4. doi: 10.1111/j.1464-410x.1988.tb04364.x.

Principles of endocrine manipulation in the treatment of prostatic cancer.

Prog Clin Biol Res. 1985;185A:73-98.

Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.

J Clin Oncol. 1986 Mar;4(3):414-24. doi: 10.1200/JCO.1986.4.3.414.

引用本文的文献

In vitro comparative models for canine and human breast cancers.

Clujul Med. 2016;89(1):38-49. doi: 10.15386/cjmed-519. Epub 2016 Jan 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验